Company: ERAS
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0000950170-25-042682
Chunk: 102

Company: Erasca, Inc.
Filing Date: 2025-03-20
Form: 10-K
Item: Item 16
Chunk 102
---
396 in fees and expenses

    21,844,660

    2

    43,602

    —

    —

    43,604

    Issuance of common stock in underwritten offering, net of $9,574 in discounts and offering costs

    99,459,458

    10

    174,416

    —

    —

    174,426

    Issuance of common stock in ATM Offering, net of $847 in commissions and expenses

    9,231,114

    1

    21,030

    —

    —

    21,031

    Exercise of stock options

    710,280

    —

    836

    —

    —

    836

    Issuance of common stock under the Employee Stock Purchase Plan

    510,729

    —

    800

    —

    —

    800

    Vesting of early exercised stock options

    —

    —

    465

    —

    —

    465

    Stock-based compensation expense

    —

    —

    26,973

    —

    —

    26,973

    Net loss

    —

    —

    —

    —

    (161,650
    )

    (161,650
    )

    Unrealized gain on marketable securities, net

    —

    —

    —

    328

    —

    328

    Balance at December 31, 2024

    283,218,344

    $
    28

    $
    1,190,729

    $
    405

    $
    (767,663
    )
     
    $
    423,499

The accompanying notes are an integral part of these consolidated financial statements.

 F-5

Erasca, Inc.

Consolidated Statements of Cash Flows

(In thousands)

    Year Ended December 31,

    2024

    2023

    Cash flows from operating activities:

    Net loss
     
    $
    (161,650
    )
     
    $
    (125,042
    )

    Adjustments to reconcile net loss to net cash used in operating activities:

    Depreciation and amortization

    3,805

    3,732

    Stock-based compensation expense

    26,973

    26,231

    In-process research and development expenses